Coping with Essential Tremor - Take Part in Research Studies

@essential tremor.org: publications: Take Part in Research Studies

	New Drug Study: "A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in the Treatment of Essential Tremor" – A randomized, double blind, placebo-controlled study to evaluate the efficacy and safety of topiramate versus a placebo in the alleviation of symptoms associated with essential tremor. This study offers an open-label extension study. The purpose of this study is to evaluate the safety and effectiveness of an investigational drug, topiramate, for the treatment of essential tremor. Eligible patients are male or female, ages 18 to 80, with a diagnosis of essential tremor. There are other inclusion/exclusion criteria for this study. The duration of the study will be approximately 11 months. Monthly visits are required. If you're interested in taking part in the study, please contact the research coordinator closest to your area:
	Stephanie Thomas, LPN University of Kansas Medical Center Department of Neurology 913-588-6921 Michele Wolff Northwestern University Chicago, Illinois 312-503-2593 Holly Delgado University of South Florida (813) 844-4477 Jacqueline Nash, RN Albany Medical Center Albany, New York 518-452-0914 Sharon Culver Colorado Neurology 303-783-4974	Patty Baron, RN Medical Neurology Rockville, Maryland 301-694-0900, Ext 250 or 229 Michael R. Halbert Neurological Research Institute of Sarasota Sarasota, Florida 941-955-5880, Ext 234 Kelly Dustin RN University of Maryland Baltimore, Maryland 410-328-7817 Dr. Adrian Handforth Veterans Affairs of Greater Los Angeles 310-268-3294 (You do not need to be a veteran to participate)